Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Phenotype C0024314|lymphoproliferative disorder
Sentences 11
PubMedID- 24868264 Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses.
PubMedID- 24374940 Mixed cryoglobulinemia is a lymphoproliferative disorder associated with hepatitis c virus (hcv).
PubMedID- 21503909 The aims of this cohort study were to evaluate the association of malignant lymphoproliferative disorders in patients with chronic viral hepatitis and to compare the results with those in individuals with non-alcoholic fatty liver disease.
PubMedID- 20945824 A high frequency of chronic lymphoproliferative disorders associated with hepatitis virus infections was found in women, especially over 50 years old.
PubMedID- 22715204 lymphoproliferative disorders associated with hepatitis c virus (hcv) make up a heterogeneous group of diseases, including lymphomas.
PubMedID- 20981794 Hcv infection of b cells is a predictive factor for lymphoproliferative disorders in patients with chronic hepatitis c, although its molecular mechanisms remain unknown.
PubMedID- 23929267 We describe a retrospective series of b-cell lymphoproliferative disorders associated with hepatitis c virus infection.
PubMedID- 24879033 Three different histological subtypes of epstein-barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis c infection.
PubMedID- 25815218 Mixed cryoglobulinemia (mc) is an autoimmune/b-cell lymphoproliferative disorder associated with hepatitis c virus (hcv) infection, manifesting as a systemic vasculitis.
PubMedID- 22128078 Patients with chronic inflammatory rheumatic disease (eg, ra, spondylarthropathy, psoriatic arthritis, gout, chondrocalcinosis or other autoimmune diseases) were excluded as well as underlying comorbidities, eg, uncontrolled diabetes, unstable ischaemic heart disease, congestive heart failure, active inflammatory bowel disease, recent stroke (within 3 months before screening), chronic leg ulcer, lymphoproliferative disorders, history of cancer, active hepatitis b or c infection, positive hiv status and persistent or recurrent infections requiring treatment with antibiotics within 30 days before enrolment.
PubMedID- 22567048 The patients were diagnosed with chronic lymphoproliferative disorders associated with hepatitis virus b/c/d infections.

Page: 1